ANCIENT HUMAN REMAINS UNLOCKED

Authors of the study (left to right: Dr. Sarah Flannery, Alexandra Morton-Hayward, Prof. Roman Fischer, and Dr. Iolanda Vendrell) in the Mass Spectrometry Lab at the Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford. (C

ANCIENT HUMAN REMAINS UNLOCKED

A new method to unlock the protein in ancient human remains could spell a revolution in historical knowledge

Published: 30 May 2025

by Caroline Wood

 

Share this article

A new method developed by researchers at the University’s Nuffield Department of Medicine could soon unlock the vast repository of biological information held in the proteins of ancient soft tissues. The findings, which could open up a new era for palaeobiological discovery, were published on 28 May in PLOS ONE.

Alexandra Morton-Hayward, forensic anthropologist and doctoral candidate at the University of Oxford, holds the two cerebellar hemispheres of a 200-year-old brain, preserved in formalin. (Credit: Graham Poulter)

From brains and muscles to stomach and skin – preserved soft tissues can offer unique insights into the past, and the lives of individuals. But up to now, this treasure trove of information has been largely inaccessible to science. In the new study, the team led by Oxford postgraduate researcher Alexandra Morton-Hayward (right) developed the first robust method for extracting and identifying proteins from ancient soft tissues, then demonstrated its capability on archaeological human brain samples.

‘Until now, studies on ancient proteins have been confined largely to mineralised tissues such as bones and teeth,’ says Morton-Hayward. ‘But the internal organs – which are a far richer source of biological information – have remained a "black box" because no established protocol existed for their analysis. Our method changes that.’

A key hurdle was finding an effective way to disrupt the cell membranes to liberate the proteins. After testing ten different strategies on samples from 200-year-old human brains excavated from a Victorian workhouse cemetery, the team discovered that urea (a major component of urine) successfully broke open the cells, liberating the proteins within.

After extraction, the proteins are then separated with liquid chromatography, and identified using mass spectrometry (an analytical technique that separates proteins based on their mass and electrical charge). The team found that by coupling the liquid chromatography-mass spectrometry step with a method called high-field asymmetric-waveform ion mobility spectrometry (which separates ions based on how they move in an electric field), they could increase the number of proteins identified by up to 40%. This makes the technique a powerful approach to recover proteins from samples that are hard to analyse, including degraded or very complex mixtures.

Morton-Hayward adds: ‘It all comes down to separation: by adding additional steps, you are more likely to confidently identify molecules of interest. It is a bit like dumping out a bucket of Lego: if you can start to discriminate between pieces by colour, then shape, then size, etc. the better chance you have of making something meaningful with it all.’

Using the combined method, the team identified over 1,200 ancient proteins from just 2.5mg of sample – by far the largest and most diverse palaeoproteome ever reported from any archaeological material. The researchers point out that proteins are an ideal vehicle to navigate the recent and deep past, as they survive far longer in the archaeological record than DNA, and can tell us about the lived experience of an individual, beyond their genetic blueprint.

Working at the Centre for Medicines Discovery at the University of Oxford, the team identified a diverse array of proteins that govern healthy brain function, reflecting the molecular complexity of the human nervous system – but also identified potential biomarkers of neurological diseases, like Alzheimer’s and multiple sclerosis. ‘The vast majority of human diseases – including psychiatric illness and mental health disorders – leave no marks on the bone, so they’re essentially invisible in the archaeological record,’ says Morton-Hayward. ‘This new technique opens a window on human history we haven’t looked through before.’

Since less than 10% of human proteins are expressed in bone compared to around 75% in internal organs, this technique promises to vastly expand our understanding of ancient diet, disease, environment and evolutionary relationships. Senior author, Professor Roman Fischer, Centre for Medicines Discovery at the University of Oxford, says: ‘By enabling the retrieval of protein biomarkers from ancient soft tissues, this workflow allows us to investigate pathology beyond the skeleton, transforming our ability to understand the health of past populations.’

The method has already attracted interest for its applicability to a wide range of archaeological materials and environments – from mummified remains to bog bodies, and from antibodies to peptide hormones.

Dr Emma Pomeroy, Associate Professor in the Evolution of Health, Diet and Disease at the University of Cambridge, who was not involved in the study, said: 'This is incredibly exciting work that will truly open up a whole host of new approaches, analyses and data sources to help us understand life, longevity, health and disease in the past, in ways that we have never been able to before.

'The methods also have the potential to offer completely new insights into the origin of some of the health problems that affect many people today, and to contribute to ongoing work to alleviate these conditions.'

The study ‘Deep palaeoproteomic profiling of archaeological human brains’ was published in PLOS One on 28 May 2025. 

The authors of the study and their affiliations are as follows:

  • Alexandra L Morton-Hayward, Department of Earth Sciences, University of Oxford; Target Discovery Institute, Centre for Medicines Discovery, University of Oxford
  • Sarah Flannery, Target Discovery Institute, University of Oxford; Centre for Medicines Discovery, University of Oxford
  • Iolanda Vendrell, Target Discovery Institute, University of Oxford; Centre for Medicines Discovery, University of Oxford
  • Roman Fischer, Target Discovery Institute, University of Oxford; Centre for Medicines Discovery, University of Oxford

Lead image: Authors of the study (left to right: Dr Sarah Flannery, Alexandra Morton-Hayward, Professor Roman Fischer, and Dr Iolanda Vendrell) in the Mass Spectrometry Lab at the Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford. (Credit: Roman Fischer)

Inset image: Alexandra Morton-Hayward, forensic anthropologist and doctoral candidate at the University of Oxford, holds the two cerebellar hemispheres of a 200-year-old brain, preserved in formalin. (Credit: Graham Poulter)